Preserving Liver Natural Killer Cell Activity: Developing Novel Culture Techniques for "Off-the-Shelf" Cell Immunotherapy

被引：0
|
作者：
Imaoka, Yuki [1 ,2 ]
Akabane, Miho [1 ]
Ohira, Masahiro [2 ]
Ohdan, Hideki [2 ]
Sasaki, Kazunari [1 ]
机构：
[1] Stanford Univ, Div Abdominal Transplant, Stanford, CA USA
[2] Hiroshima Univ, Gastroenterol & Transplant Surg, Hiroshima, Japan
来源：
TRANSPLANTATION | 2023年 / 107卷 / 10期
关键词：
D O I：
10.1097/01.tp.0000994700.79816.86
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
411.4
引用
收藏
页码：169 / 169
页数：1
相关论文
共 50 条
  • [41] Novel targets for natural killer/T-cell lymphoma immunotherapy
    Kumai, Takumi
    Kobayashi, Hiroya
    Harabuchi, Yasuaki
    IMMUNOTHERAPY, 2016, 8 (01) : 45 - 55
  • [42] Off-the-shelf EBV-specific T-cell Immunotherapy for EBV-associated PTLD
    O'Reilly, Maeve
    Peggs, Karl S.
    TRANSPLANTATION, 2020, 104 (10) : 1972 - 1973
  • [43] Optimal, Off-the-Shelf, CAR-iNKT Cell Platform-Based Immunotherapy for Multiple Myeloma
    Ponnusamy, Kanagaraju
    Randzavola, Lyra
    Ren, Hongwei
    Karaxhuku, Klesti
    Lye, Bryan
    Leonardos, Dimitrios
    Nadafi, Reza
    Sarkar, Irene
    Leontari, Ilia
    Sabrin, Farah
    Zaidi, Mehmood
    Bua, Marco
    Atta, Maria
    Katsarou, Alexia
    Roberts, Irene
    Chaidos, Aristeidis
    Karadimitris, Anastasios
    BLOOD, 2023, 142
  • [44] Generation of an off-the-shelf cell-based platform (PDC-vac) for active antitumor immunotherapy
    Plumas, Joel
    Lenogue, Kevin
    Walencik, Alexandre
    Molens, Jean-Paul
    Chaperot, Laurence
    Pule, Martin
    CANCER RESEARCH, 2017, 77
  • [45] Towards off-the shelf Natural Killer cell products for the treatment of ovarian cancer
    Weis, Anna
    Sheedy, Aoibhin
    Geller, Melissa
    Shetty, Mihir
    Felices, Martin
    Benzdick, Laura
    Miller, Jeff
    Dolan, Eimear
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A260 - A262
  • [46] Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
    Li, Yan-Ruide
    Dunn, Zachary Spencer
    Garcia, Gustavo, Jr.
    Carmona, Camille
    Zhou, Yang
    Lee, Derek
    Yu, Jiaji
    Huang, Jie
    Kim, Jocelyn T.
    Arumugaswami, Vaithilingaraja
    Wang, Pin
    Yang, Lili
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [47] Genetic engineering of natural killer cells for off-the-shelf cell therapy strategies against cervical cancer: targeting Mesothelin and Fibroblast activation protein
    Polten, R.
    Kutle, I.
    Hachenberg, J.
    Hass, R.
    Schott, J.
    von der Ohe, J.
    Seyda, A. K.
    Hillemanns, P.
    Morgan, M.
    Klapdor, R.
    Schambach, A.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A23 - A24
  • [48] Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention
    Yan-Ruide Li
    Zachary Spencer Dunn
    Gustavo Garcia
    Camille Carmona
    Yang Zhou
    Derek Lee
    Jiaji Yu
    Jie Huang
    Jocelyn T. Kim
    Vaithilingaraja Arumugaswami
    Pin Wang
    Lili Yang
    Stem Cell Research & Therapy, 13
  • [49] Development of Off-the-Shelf Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cells for COVID-19 Therapeutic Intervention
    Li, Yanruide
    MOLECULAR THERAPY, 2023, 31 (04) : 639 - 639
  • [50] cGMP Mass Production of FT538, a First-of-Kind, Off-the-Shelf, Multiplexed Engineered Natural Killer Cell Cancer Immunotherapy Derived from a Clonal Master Induced Pluripotent Stem Cell Line
    Rezner, Betsy
    Solchaga, Luis
    Reyes, Luane
    Lin, Alice
    Abujarour, Ramzey
    Lee, Tom
    Valamehr, Bahram
    Wang, Wen Bo
    BLOOD, 2020, 136
12345